Treatment of uterine myoma.

Phase 3

• Conditions: fibromyoma of uterus.; Leiomyoma of uterus; fibromyoma of uterus

• Registration Number: IRCT201403092624N12
• Lead Sponsor: Vice chancellor for research ,Iran University of Medical Sciences.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

symptomatic myoma including abnormal uterine bleeding ( after excluding the other etiologies), pelvic pain, and myoma in ultrasound with a minimum size of 2 centimeters.
Exclusion criteria : severe bleeding; pregnancy; breast feeding; using any hormone or sedative; any other pathology in ultrasound; any known hormonal problems and any conditions need to an emergency treatment.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in the size of myoma. Timepoint: 3 months after treatment. Method of measurement: Ultrasound.

Secondary Outcome Measures

Name	Time	Method
Change of the symptoms including pelvic pain and amount of bleeding. Timepoint: 3 months after treatment. Method of measurement: Questionair and VAS.